The groundbreaking approach of the medication represents a major breakthrough in the management of the condition. Distinct from existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide974112.idblogz.com/42360182/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment